MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway

References

• Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J B.U.ON. 2016;21:320–325.
   Google Scholar
• Zhang S, McNamara M, Batur P. Cervical cancer screening: what’s new? Updates for the busy clinician. Am J Med. 2018;131:702.e1–702.e5.
   Web of Science ®Google Scholar
• Wardak S. Human Papillomavirus (HPV) and cervical cancer. Medycyna doswiadczalna i mikrobiologia. 2016;68:73–84.
   PubMedGoogle Scholar
• Olusola P, Banerjee H, Philley J, et al. Human papilloma virus-associated cervical cancer and health disparities. Cells. 2019;8(6):622.
   PubMed Web of Science ®Google Scholar
• Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217–5236.
   PubMed Web of Science ®Google Scholar
• Cubie H, Campbell C. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: focus on Malawi. Women’s Health (London, England). 2020;16:1745506520914804.
   Google Scholar
• Acharya Pandey R, Karmacharya E. Cervical cancer screening behavior and associated factors among women of Ugrachandi Nala, Kavre, Nepal. Eur J Med Res. 2017;22(1):32.
   PubMedGoogle Scholar
• Lu T, Rothenberg M. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15:429.
   PubMed Web of Science ®Google Scholar
• Yu F, Liu J, Dong W, et al. The diagnostic value of miR-145 and miR-205 in patients with cervical cancer. Am J Transl Res. 2021;13:1825–1832.
   PubMed Web of Science ®Google Scholar
• Jiang L, Shi S, Li F, et al. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling. Mol Med Rep. 2021;23(5). doi: 10.3892/mmr.2021.11992.
   Web of Science ®Google Scholar
• Wang Z, Ren C, Yang L, et al. Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4. Aging (Albany NY). 2021;13:9119–9134.
   PubMedGoogle Scholar
• You X, Wang Y, Meng J, et al. Exosomal miR‑663b exposed to TGF‑β1 promotes cervical cancer metastasis and epithelial‑mesenchymal transition by targeting MGAT3. Oncol Rep. 2021;45:1.
   PubMed Web of Science ®Google Scholar
• Jun T, Chen W, Hailing C, et al. The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis. Hum Cell. 2021;34(3):878–888.
   PubMed Web of Science ®Google Scholar
• Rongrong X, Xiaoyue Z, Yan X, et al. Long noncoding RNA MST1P2 promotes cervical cancer progression by sponging with microRNA miR-133b. Bioengineered. 2021;12:1851–1860.
   PubMed Web of Science ®Google Scholar
• Xuehe W, Huaqin S, Simin Z. Long non-coding RNA PTAR inhibits apoptosis but promotes proliferation, invasion and migration of cervical cancer cells by binding miR-101. Bioengineered. 2021;12:4536–4545.
   PubMed Web of Science ®Google Scholar
• Shimei L, Bingqing L, Ying L, et al. Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis. Bioengineered. 2021;12:4397–4406.
   PubMed Web of Science ®Google Scholar
• Xu T, Song X, Wang Y, et al. Genome-Wide analysis of the expression of circular RNA full-length transcripts and construction of the circRNA-miRNA-mRNA network in cervical cancer. Front Cell Dev Biol. 2020;8:603516.
   PubMed Web of Science ®Google Scholar
• Liping L, Pingping M, Yao M, et al. ViaCirc-ZFR promotes progression of bladder cancer by upregulating WNT5A sponging miR-545 and miR-1270. Front Oncol. 2020;10:596623.
   PubMedGoogle Scholar
• Lei Y, Wei Z, Peng W, et al. LncRNA SNHG11 aggravates cell proliferation and migration in triple-negative breast cancer via sponging miR-2355-5p and targeting CBX5. Exp Ther Med. 2021;22:892.
   PubMed Web of Science ®Google Scholar
• Huiting X, Runzhi C, Qian S, et al. Overexpression of circular RNA circ_0013587 reverses erlotinib resistance in pancreatic cancer cells through regulating the miR-1227/E-Cadherin pathway. Front Oncol. 2021;11:754146.
   PubMed Web of Science ®Google Scholar
• Fu B, Wei L, Cui Z, et al. Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis. Int J Biol Sci. 2021;17:3104–3117.
   PubMed Web of Science ®Google Scholar
• Fu B, Wei L, Ying Z, et al. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer. Sci Rep. 2015;5:8029.
   PubMed Web of Science ®Google Scholar
• Chunlei W, Jiange Z. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma. Biosci Rep. 2020;40:undefined.
   Web of Science ®Google Scholar
• Yu B, Zhao J, Dong Y. Circ_0000527 promotes retinoblastoma progression through modulating miR-98-5p/XIAP pathway. Curr Eye Res. 2021;46(9):1414-1423.
   Web of Science ®Google Scholar
• Li Y, Wang X, Zhao Z, et al. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1. Biosci Rep. 2021;41(7). doi: 10.1042/BSR20200767
   Google Scholar
• Dong L, Cao X, Luo Y, et al. A positive feedback loop of lncRNA DSCR8/miR-98-5p/STAT3/HIF-1α plays a role in the progression of ovarian cancer. Front Oncol. 2020;10:1713.
   PubMed Web of Science ®Google Scholar
• Sun D, Luo X, Ma L, et al. Identifying of miR-98-5p/IGF1 axis contributes breast cancer progression using comprehensive bioinformatic analyses methods and experiments validation. Life Sci. 2020;261:118435.
   PubMed Web of Science ®Google Scholar
• Lee Y, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.
   PubMed Web of Science ®Google Scholar
• Panda A. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Zhan P, Shu X, Chen M, et al. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. Life Sci. 2021;276:119405.
   PubMed Web of Science ®Google Scholar
• Shen Q, Jiang S, Wu M, et al. LncRNA HEIH confers cell sorafenib resistance in hepatocellular carcinoma by regulating miR-98-5p/PI3K/AKT pathway. Cancer Manag Res. 2020;12:6585–6595.
   PubMed Web of Science ®Google Scholar
• Gu N, Wang X, Di Z, et al. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis. Aging (Albany NY). 2019;11:10266–10283.
   PubMedGoogle Scholar
• Haddadi N, Lin Y, Travis G, et al. PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy. Mol Cancer. 2018;17:37.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Su Y, et al. miRNA-98-5p targeting IGF2BP1 induces mesenchymal stem cell apoptosis by modulating PI3K/Akt and p53 in immune thrombocytopenia. Mol Ther Nucleic Acids. 2020;20:764–776.
   PubMedGoogle Scholar